Siemens Healthineers announces FDA clearance of Cios Spin Mobile 3D C-Arm

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-arm that delivers precise 3D images for intraoperative quality assurance. By enabling surgeons to perform intraoperative corrections based on 3D images and confirm their results, the Cios Spin can help surgeons work with greater precision, transform the delivery of patient care, and achieve optimal treatment results.

Capable of integrating seamlessly into the clinical routine, the Cios Spin provides 3D computed tomography (CT)-like imaging for orthopedic, trauma and spine surgery. These 3D images can help reduce the rate of revisions with intraoperative evaluation as well as the need for post-operative CT. Cios Spin provides versatility to support both 2D and 3D imaging for a wide variety of procedures, including vascular imaging. The system’s NaviLink 3D digital navigation provides easy-to-use connectivity to surgical navigation.

Cios Spin is equipped with state-of-the-art flat panel detector technology and is available with a range of optional software packages. The Easy 3D package ensures fast, efficient setup, and image acquisition. The Screw Scout package enables system software to recognize and automatically label screws in a 3D X-ray image, saving time and effort for the surgeon.

The system’s high generator power addresses the challenge of imaging large patients and dense anatomy to enable precise clinical evaluation of images. And the Cios Spin is the first commercially available mobile C-arm with an antimicrobial coating for comprehensive infection control.

“Siemens Healthineers is proud to offer the Cios Spin, a dynamic new mobile 3D C-arm that illustrates our expertise in mobile X-ray imaging,” said Robert Dewey, Vice President of Surgical Solutions at Siemens Healthineers North America. “This system will help our customers improve the quality of patient care using precision medicine as well as reduce the additional costs imposed by revision surgery.”

Around the web

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.